DE602004024916D1 - Synthese von dipeptidanaloga - Google Patents

Synthese von dipeptidanaloga

Info

Publication number
DE602004024916D1
DE602004024916D1 DE602004024916T DE602004024916T DE602004024916D1 DE 602004024916 D1 DE602004024916 D1 DE 602004024916D1 DE 602004024916 T DE602004024916 T DE 602004024916T DE 602004024916 T DE602004024916 T DE 602004024916T DE 602004024916 D1 DE602004024916 D1 DE 602004024916D1
Authority
DE
Germany
Prior art keywords
synthesis
dipeptide analog
dipeptide
analog
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004024916T
Other languages
English (en)
Inventor
C A Busacca
N Haddad
S R Kapadia
Keenan L Smith
J C Lorenz
C H Senanayake
X Wei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharmaceuticals Inc
Publication of DE602004024916D1 publication Critical patent/DE602004024916D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602004024916T 2003-10-30 2004-10-27 Synthese von dipeptidanaloga Active DE602004024916D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51584803P 2003-10-30 2003-10-30
PCT/US2004/035833 WO2005044799A1 (en) 2003-10-30 2004-10-27 Dipeptide-analogue synthesis

Publications (1)

Publication Number Publication Date
DE602004024916D1 true DE602004024916D1 (de) 2010-02-11

Family

ID=34572859

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004024916T Active DE602004024916D1 (de) 2003-10-30 2004-10-27 Synthese von dipeptidanaloga

Country Status (7)

Country Link
US (1) US7186827B2 (de)
EP (1) EP1682506B1 (de)
JP (1) JP2007509961A (de)
AT (1) ATE453623T1 (de)
CA (1) CA2543884A1 (de)
DE (1) DE602004024916D1 (de)
WO (1) WO2005044799A1 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2251892A (en) 1991-06-14 1993-01-12 Chiron Corporation Inhibitors of picornavirus proteases
US5804560A (en) 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
GB9723407D0 (en) 1997-11-05 1998-01-07 Ciba Geigy Ag Organic compounds
ATE479651T1 (de) 1997-11-05 2010-09-15 Novartis Pharma Gmbh Dipeptide nitrile
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
US7326719B2 (en) * 2003-03-13 2008-02-05 Boehringer Ingelheim Pharmaceuticals, Inc. Cathepsin S inhibitors

Also Published As

Publication number Publication date
CA2543884A1 (en) 2005-05-19
ATE453623T1 (de) 2010-01-15
WO2005044799A1 (en) 2005-05-19
EP1682506A1 (de) 2006-07-26
EP1682506B1 (de) 2009-12-30
US20050113572A1 (en) 2005-05-26
JP2007509961A (ja) 2007-04-19
US7186827B2 (en) 2007-03-06

Similar Documents

Publication Publication Date Title
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
SE0302811D0 (sv) Novel compounds
CO5611065A2 (es) Difluorometiltiazolilcarboxanilidas
TW200503724A (en) Novel pharmaceuticals
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
HK1089444A1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
NO20050741L (no) Ny fremgangsmate for syntesen og ny krystallinsk form av agomelatin og farmasoytiske sammensetninger inneholdende den
TW200621779A (en) Process for the manufacture of dihydropteridinones
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
SE0202133D0 (sv) Novel compounds
DE602004024213D1 (en) Aminopropanolderivate
ATE427953T1 (de) Fondaparinux- natrium zusammenstellung von hoher reinheit
SE0403171D0 (sv) New compounds
MXPA04006266A (es) Pirimidotriazinas como inhibidores de fosfatasa.
NO20063293L (no) Farmasoytiske forbindelser
DE602004029355D1 (de) Sulfopyrrolderivate
DE50310579D1 (de) Furancarboxamide
GB0327323D0 (en) Novel pharmaceuticals
MXPA05010398A (es) Nuevo metodo para la sintesis del acido (2s)-indolin-2-carboxilico y aplicacion de mismo en la sintesis del perindopril.
DK1644385T3 (da) Siliciumforbindelser og deres anvendelse
DE50311756D1 (de) Mikrobizide oxathiincarboxamide
GB2441840A (en) Process for the synthesis of arylfluorenes and analogues thereof
AU2003243381A8 (en) Variants of antithrombin iii
DE602004024916D1 (de) Synthese von dipeptidanaloga
BR0309526A (pt) Metiltiofenocarboxanilidas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition